In MM patients with high MYC expression, the efficacy of IMiD treatment was improved compared with MM patients with low MYC expression (Figure S3E) and this trend was further amplified when we compared YAP-MYC+ MM patients with the rest (Figure 3E and Figure S3F). The gene discussed is YAP1; the disease is Miyoshi myopathy.